Liquidia Technologies, Inc. (LQDA) (“Liquidia”), a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT® technology to transform the lives of patients, today announced that it has been added to the Russell 2000®, Russell 3000® and Russell Microcap® Indexes, effective after market close on September 21, 2018, as part of Russell’s quarterly addition of companies with recent initial public offerings.
The Russell 2000 Index measures the performance of the small-cap segment of the U.S. equity market and is a subset of the Russell 3000. Membership in the Russell 2000 Index includes automatic inclusion in the appropriate growth and value indexes, such the Russell Microcap Index. The Russell Microcap Index represents small-cap and micro-cap stocks.
“Inclusion in the Russell 2000, Russell 3000 and Russell Microcap Indexes offers the opportunity to broaden Liquidia’s presence within the investment community,” said Neal Fowler, Chief Executive Officer of Liquidia. “We are pleased to be added to these indexes and believe that we are well-positioned following our successful initial public offering in July.”
Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately $9 trillion in assets are benchmarked against Russell’s U.S. indexes. Russell indexes are part of FTSE Russell, a leading global index provider.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.